A detailed history of Albion Financial Group transactions in Pfizer Inc stock. As of the latest transaction made, Albion Financial Group holds 2,254 shares of PFE stock, worth $60,226. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,254
Previous 1,292 74.46%
Holding current value
$60,226
Previous $36,000 80.56%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$27.7 - $31.39 $26,647 - $30,197
962 Added 74.46%
2,254 $65,000
Q2 2024

Jul 10, 2024

SELL
$25.26 - $29.6 $5,557 - $6,512
-220 Reduced 14.55%
1,292 $36,000
Q1 2024

Apr 19, 2024

SELL
$25.89 - $29.73 $802 - $921
-31 Reduced 2.01%
1,512 $41,000
Q4 2023

Jan 26, 2024

BUY
$26.13 - $33.94 $810 - $1,052
31 Added 2.05%
1,543 $44,000
Q3 2023

Nov 01, 2023

SELL
$32.09 - $37.51 $352 - $412
-11 Reduced 0.72%
1,512 $50,000
Q2 2023

Jul 25, 2023

BUY
$36.12 - $41.79 $397 - $459
11 Added 0.73%
1,523 $55,000
Q1 2023

Apr 18, 2023

SELL
$39.39 - $51.28 $30,724 - $39,998
-780 Reduced 34.03%
1,512 $61,000
Q4 2022

Feb 03, 2023

BUY
$41.75 - $54.5 $208 - $272
5 Added 0.22%
2,292 $117,000
Q3 2022

Oct 27, 2022

BUY
$43.76 - $53.42 $306 - $373
7 Added 0.31%
2,287 $100,000
Q2 2022

Jul 29, 2022

SELL
$46.53 - $55.17 $74,168 - $87,940
-1,594 Reduced 41.15%
2,280 $120,000
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $10,202 - $12,641
-223 Reduced 5.44%
3,874 $201,000
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $1,900 - $2,817
46 Added 1.14%
4,097 $242,000
Q3 2021

Oct 19, 2021

SELL
$39.25 - $50.42 $4,082 - $5,243
-104 Reduced 2.5%
4,051 $174,000
Q2 2021

Aug 12, 2021

SELL
$35.91 - $40.68 $31,421 - $35,595
-875 Reduced 17.4%
4,155 $163,000
Q4 2020

Feb 19, 2021

SELL
$33.47 - $42.56 $26,508 - $33,707
-792 Reduced 13.6%
5,030 $185,000
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $184,848 - $216,869
5,822 New
5,822 $214,000
Q1 2020

May 08, 2020

SELL
$27.03 - $38.62 $168,450 - $240,679
-6,232 Closed
0 $0
Q4 2019

Jan 31, 2020

SELL
$32.92 - $37.36 $49,215 - $55,853
-1,495 Reduced 19.35%
6,232 $244,000
Q3 2019

Nov 08, 2019

SELL
$32.49 - $42.13 $476,530 - $617,920
-14,667 Reduced 65.5%
7,727 $278,000
Q2 2019

Aug 08, 2019

SELL
$36.98 - $41.52 $20,708 - $23,251
-560 Reduced 2.44%
22,394 $970,000
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $2,625 - $2,884
-70 Reduced 0.3%
22,954 $975,000
Q3 2018

Nov 20, 2018

SELL
$34.47 - $41.81 $31,023 - $37,629
-900 Reduced 3.76%
23,024 $1.02 Million
Q1 2018

Apr 17, 2018

SELL
$31.91 - $37.02 $31,910 - $37,020
-1,000 Reduced 4.01%
23,924 $849,000
Q4 2017

Feb 22, 2018

SELL
$33.26 - $35.29 $17,128 - $18,174
-515 Reduced 2.02%
24,924 $903,000
Q3 2017

Nov 09, 2017

SELL
$31.0 - $34.15 $21,483 - $23,665
-693 Reduced 2.65%
25,439 $908,000
Q2 2017

Aug 15, 2017

BUY
N/A
26,132
26,132 $878,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Albion Financial Group Portfolio

Follow Albion Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

News

Stay updated on Albion Financial Group with notifications on news.